<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Hemoglobin A1c Test for Pediatric Patients</title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <h1 class="h1center">Hemoglobin A1c Test for Pediatric Patients (NQF 0060)</h1>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Name</span></td>
               <td width="30%">Hemoglobin A1c Test for Pediatric Patients</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Id</span></td>
               <td width="30%"> 02BA6629-ACB9-4A5F-8C02-061BC9A71186</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Version number</span></td>
               <td width="30%">1</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Set Id</span></td>
               <td width="30%"> 593A4765-9B49-4121-B0FD-6B94469591B0</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Available Date</span></td>
               <td width="30%"> No information </td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td>January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">National Committee for Quality Assurance</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed by</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">Percentage of pediatric patients with diabetes with a HBA1c test in a 12-month measurement period</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3"><pre>&copy; National Committee for Quality Assurance. All Rights Reserved</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Data Aggregation</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3"><pre>Prolonged hyperglycemia causes nonenzymatic glycosylation of proteins in tissue and blood, including hemoglobin in erythrocytes. Similar glycosylation of tissue proteins may be involved in pathologic processes which occur in the microvasculature in diabetes. Measurement of glycated proteins such as hemoglobin or other serum proteins can quantify average levels of blood glucose over a period of weeks to months depending on the component measured. In the case of glycosylated hemoglobin, this corresponds to about the life cycle of a red blood cell, or 120 days (3 months). Other glycated serum proteins, such as fructosamine, represent short term changes in glycemia on the order of one to two weeks. The relationship of glucose levels over time to glycohemoglobin makes it a convenient long-term measure of glycemic control. Considering the interval during which glycosylation of hemoglobin occurs, the American Diabetes Association (ADA) recommends testing frequency from one to four times a year depending on the stability of control (ADA, 1997a).

The measurement of glycohemoglobin levels is therefore an important way to identify and anticipate risk for early microvascular complications which result ultimately in the devastating outcomes of blindness, amputation, and kidney failure. It has now been established that early anticipation of risk allows effective intervention through intensive treatment of diabetes.

Even though most target recommendations for glycemic control have been based on data obtained from studies of adult patients with diabetes, the ideal goal of near-normalization of blood glucose levels in children and adolescents is generally the same as that for adults. However, special consideration must be given to the unique risks of hypoglycemia in young children.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3"><pre>1. American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE): 
Recommend that a glycosylated hemoglobin be performed during an initial assessment and during follow-up assessments, which should occur at no longer than three-month intervals (AACE/ACE, 2002 and 2000).

2. American Diabetes Association (ADA, 2006): 
Recommends obtaining a glycosylated hemoglobin during an initial assessment and then routinely as part of continuing care. In the absence of well-controlled studies that suggest a definite testing protocol, expert opinion recommends glycosylated hemoglobin be obtained at least twice a year in patients who are meeting treatment goals and who have stable glycemic control and more frequently (quarterly assessment) in patients whose therapy was changed or who are not meeting glycemic goals.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement notation</span></td>
               <td width="80%" colspan="3"><pre>Higher scores indicate better quality</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement duration</span></td>
               <td width="80%" colspan="3"><pre>24 month(s)</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>ADA. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 20(Suppl. 1):S5-S13, 1997.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>ADA. Standards of medical care in Diabetes-2006. Diabetes Care, vol 29, Supplement 1. January 2006.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>American Association of Clinical Endocrinologists and American College of Endocrinology. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management-2002 Update. Endocrine Practice. Jan/Feb 2002;8(1)</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Initial Patient Population(s): All patients 18 to 75 years of age during the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator(s): Patients in the initial population with a diagnosis of diabetes and at least 2 non-acute inpatient or outpatient encounters, or currently receiving medications indicative of diabetes during the measurement period or in the 12 months prior to the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exclusion(s): Patients with a diagnosis of polycystic ovaries, gestational diabetes or steroid-induced diabetes who did not have any face-to-face encounters in any setting, with a diagnosis of diabetes, during the measurement period or the 12 months prior to the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Numerator(s): An HbA1c test performed during the measurement year</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exception(s): N/A</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3"><pre>Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".</pre></td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d84571e372">Population criteria</a></li>
         <li><a href="#d84571e1279">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d84571e1671">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d84571e372" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic: birth date"  &gt;= 4 year(s) starts before start of "Measurement period"</li>
                  <li>AND: "Patient Characteristic: birth date"  &lt;= 16 year(s) starts before start of "Measurement period"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
                  <li>AND: 
                     <ul>
                        <li>OR: 
                           <ul>
                              <li>AND: "Diagnosis, Active: diabetes"</li>
                              <li>AND: 
                                 <ul>
                                    <li>OR: "Encounter: Encounter acute inpatient or ED"</li>
                                    <li>OR: 
                                       <ul>
                                          <li>AND: Count &gt;= 2  of:"Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"</li>
                                          <li>AND: FIRST:"Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"  &gt;= 1 day(s) starts before start of SECOND
                                             :"Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"
                                          </li>
                                       </ul>
                                       
                                    </li>
                                 </ul>
                                 
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: "Medication, Dispensed: Medications indicative of diabetes"</li>
                        <li>  &lt;= 2 year(s) starts before or during "Measurement end date"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>AND NOT: "Diagnosis, Active: diabetes"</li>
                        <li>AND NOT: 
                           <ul>
                              <li>OR: "Encounter: Encounter acute inpatient or ED"</li>
                              <li>OR: "Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"</li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Diagnosis, Active: gestational diabetes"</li>
                        <li>OR: "Diagnosis, Active: steroid induced diabetes"</li>
                     </ul>
                     
                  </li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Medication, Order: Medications indicative of diabetes"</li>
                        <li>OR: "Medication, Active: Medications indicative of diabetes"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Numerator =</b>
               
               <ul>
                  <li>AND: "Laboratory Test, Result: HbA1c test" during "Measurement period"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d84571e1279" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: diabetes" using "diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.37)"
            </li>
            <li>
               "Diagnosis, Active: gestational diabetes" using "gestational diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.67)"
            </li>
            <li>
               "Diagnosis, Active: steroid induced diabetes" using "steroid induced diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.113)"
            </li>
            <li>
               "Encounter: Encounter acute inpatient or ED" using "Encounter acute inpatient or ED Value Set GROUPING (2.16.840.1.113883.3.464.0001.42)"
            </li>
            <li>
               "Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology" using "Encounter non-acute inpatient, outpatient, or ophthalmology Value Set GROUPING (2.16.840.1.113883.3.464.0001.47)"
            </li>
            <li>
               "Laboratory Test, Result: HbA1c test" using "HbA1c test Value Set GROUPING (2.16.840.1.113883.3.464.0001.72)"
            </li>
            <li>
               "Medication, Active: Medications indicative of diabetes" using "Medications indicative of diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.94)"
            </li>
            <li>
               "Medication, Dispensed: Medications indicative of diabetes" using "Medications indicative of diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.94)"
            </li>
            <li>
               "Medication, Order: Medications indicative of diabetes" using "Medications indicative of diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.94)"
            </li>
            <li>
               "Patient Characteristic: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d84571e1671" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>"Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"</li>
            <li>"Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"</li>
            <li>"Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"</li>
            <li>"Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)"</li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure set</span></td>
               <td colspan="3">CLINICAL QUALITY MEASURE SET 2011-2012</td>
            </tr>
         </tbody>
      </table>
   </body>
</html>